Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-013068
Filing Date
2025-05-30
Accepted
2025-05-30 16:45:35
Documents
17
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm   iXBRL PRE 14A 1130010
2 GRAPHIC proxy_001.jpg GRAPHIC 346110
3 GRAPHIC proxy_002.jpg GRAPHIC 164988
  Complete submission text file 0001641172-25-013068.txt   3068938

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE imnn-20241231.xsd EX-101.SCH 4578
5 XBRL DEFINITION FILE imnn-20241231_def.xml EX-101.DEF 8910
6 XBRL LABEL FILE imnn-20241231_lab.xml EX-101.LAB 59552
7 XBRL PRESENTATION FILE imnn-20241231_pre.xml EX-101.PRE 44606
19 EXTRACTED XBRL INSTANCE DOCUMENT formpre14a_htm.xml XML 147076
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15911 | Film No.: 251011735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)